Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13
Item hits:
Issue DateTitleAuthor(s)
1-Mar-2019Increased COPD exacerbations of likely viral etiology follow elevated ambient nitrogen oxidesPfeffer, PE; Donaldson, GC; Mackay, AJ; Wedzicha, JA; , et al
1-Jan-2019Capturing exacerbations of chronic obstructive pulmonary disease with EXACT: A sub-analysis of FLAMEFrent, SM; Chapman, KR; Larbig, M; Mackay, A; Fogel, R, et al
18-May-2019Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD Science Committee Report 2019Singh, D; Agusti, A; Anzueto, A; Barnes, PJ; Bourbeau, J, et al
8-Jan-2019Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME studyWedzicha, JA; Singh, D; Tsiligianni, I; Jenkins, C; Fucile, S, et al
8-Mar-2019The etiological role of common respiratory viruses in acute respiratory infections in older adults: a systematic review and meta-analysisShi, T; Arnott, A; Semogas, I; Falsey, AR; Openshaw, P, et al
15-Jan-2019ILD: Upcoming themed issueMartinez, FJ; Wedzicha, JA
1-Feb-2019Reply to: Different background, short duration, inappropriate participants may harm your conclusionChapman, KR; Hurst, JR; Fogel, RB; Pfister, P; Kostikas, K, et al
28-Aug-2019Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary diseaseSinganayagam, A; Glanville, N; Cuthbertson, L; Bartlett, NW; Finney, LJ, et al
1-Oct-2019A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocolRabe, KF; Martinez, FJ; Ferguson, GT; Wang, C; Singh, D, et al
26-Sep-2019Update on clinical aspects of chronic obstructive pulmonary diseaseCelli, BR; Wedzicha, JA